Bernardo Mendoza, MD
Vascular Surgery · Tucson, AZNPI 1609980499
Payments from drug & device makers
What this record shows
This record is dominated by other: $27,500 of the $32,800 with a category attached, or 83.8%. Angiodynamics, Inc. accounts for 83.8% of it on its own, with 35 other manufacturers making up the rest. 2025 is the largest year on record at $16,086, more than ten times the $513 reported in 2019.
Across 176 payments — averaging $186.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$28K
- Abbott$1K
- Inari Medical, Inc.$708
- W. L. Gore & Associates, Inc.$496
- Stryker$386
- Bard Peripheral Vascular, Inc.$270
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,30016%
- Other$27,50084%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 2 | $27,500 |
| Abbott | 44 | $1,178 |
| Inari Medical, Inc. | 13 | $708 |
| W. L. Gore & Associates, Inc. | 14 | $496 |
| Stryker | 8 | $386 |
| Bard Peripheral Vascular, Inc. | 8 | $270 |
| Penumbra, Inc. | 7 | $266 |
| Recor Medical Inc | 3 | $241 |
| Medtronic(2 entities) | 9 | $215 |
| Cvrx, Inc. | 7 | $150 |
| Tactile Systems Technology Inc | 7 | $147 |
| Intact Vascular, Inc. | 1 | $142 |
| Endologix LLC | 1 | $130 |
| Cook Medical LLC | 3 | $121 |
| Novartis | 6 | $106 |
| Pfizer | 6 | $105 |
| Boston Scientific | 3 | $71 |
| Silk Road Medical, Inc. | 3 | $69 |
| Lemaitre Vascular, Inc. | 5 | $68 |
| Integra Lifesciences Corporation | 4 | $57 |
| Johnson & Johnson | 4 | $54 |
| Cardiva Medical, Inc. | 3 | $51 |
| Smith+Nephew | 2 | $34 |
| Veryan Medical Incorporated | 1 | $27 |
| BD | 1 | $24 |
| Misonix Inc | 1 | $23 |
| Kestra Medical Technology Services, Inc. | 1 | $22 |
| Terumo Medical Corporation | 1 | $22 |
| Asahi Intecc USA, Inc. | 1 | $21 |
| Nevro Corp. | 1 | $20 |
| Baxter Healthcare | 1 | $20 |
| Solventum Corporation | 1 | $16 |
| Kerecis Limited | 1 | $15 |
| Medela LLC | 1 | $14 |
| Artivion, Inc. | 1 | $7 |
| Surmodics, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$27,500
- FlowTriever$454
- ClotTriever$454
- FLOWTRIEVER CATHETER, S$237
- CT THROMBECTOMY SYSTEM KIT$237
- Indigo System$171
- Lutonix Drug Coated Balloon$158
- Conformable TAG Thoracic Endoprosthesis$144
- Tack Endovascular System$142
- Supera peripheral stent system$134
- AFX2 Bifurcated Endograft System$130
- PARADISE RENAL DENERVATION SYSTEM$120
- JETi Peripheral Catheter$116
How this compares
$32,800 in reported general payments places this provider in the 80th percentile of 105 vascular surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 15 | $8,787 |
| EliquisApixaban | 14 | $8,689 |
| ClopidogrelClopidogrel Bisulfate | 90 | $1,031 |
| Cephalexin | 16 | $139 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $130 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 25 | $97 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $54 | $8,78715 claims |
| PfizerEliquis | $105 | $8,68914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 105 vascular surgery providers in Arizona.
Other vascular surgery in Tucson
- Joshua BaldermanTucson$135K
- John PacanowskiTucson$85K
- Joseph SabatTucson$48K
- Federico YanquezTucson$31K
- Christopher ComptonTucson$27K
- Matthew NamannyTucson$25K
- Lauren BeliveauTucson$24K
- Eric BerensTucson$19K
- Layla LucasTucson$16K
- Codyjo KraemerTucson$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.